Adjuvant therapy with bicalutamide 150 mg versus standard care alone: third analysis results from Trial 24 of the Early Prostate Cancer Programme

Simple item page
dc.contributor.authorWirth M
dc.contributor.authorTyrrell C
dc.contributor.authorDelaere K
dc.contributor.authorSanches-Chapado M
dc.contributor.authorRamon J
dc.contributor.authorWallace M
dc.contributor.authorHetherington J
dc.contributor.authorPina F
dc.contributor.authorHeyns CF
dc.contributor.authorBorchers T
dc.contributor.authorNavani S
dc.contributor.authorArmstrong J
dc.date.accessioned2012-08-10T13:29:06Z
dc.date.available2012-08-10T13:29:06Z
dc.date.issued2006
dc.descriptionPlease help us populate SUNScholar with the post print version of this article. It can be e-mailed to: scholar@sun.ac.za
dc.descriptionGeneeskunde
dc.descriptionUrologie
dc.identifier.urihttp://hdl.handle.net/10019.1/37498
dc.titleAdjuvant therapy with bicalutamide 150 mg versus standard care alone: third analysis results from Trial 24 of the Early Prostate Cancer Programme
dc.typeProceedings International
Files
Collections
2006 - Research Outputs